Drug intelligence / Profile preview

Jiuweihuaban Pill

Development stage
Phase 2
Lead developer
Tasly Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Jiuweihuaban Pill is a traditional Chinese medicine (TCM) composition developed by Tasly Pharmaceutical Group Co., Ltd for the treatment of moderate to severe plaque psoriasis, specifically targeting the "blood-heat syndrome" pattern according to TCM theory. It is a nine-ingredient botanical and animal-derived formulation consisting of baical skullcap root (*Scutellaria baicalensis*), Japanese honeysuckle flower (*Lonicera japonica*), red peony root (*Paeonia lactiflora*), tree peony bark (*Paeonia suffruticosa*), gypsum, charred cape jasmine fruit (*Gardenia jasminoides*), garden burnet root (*Sanguisorba officinalis*), liquorice root (*Glycyrrhiza uralensis*), and buffalo horn powder. The drug is currently being evaluated in Phase II clinical trials (NCT06058546) to assess its efficacy and safety in reducing psoriasis symptoms and improving patient outcomes.

Brand names
jiuweihuaban pill
Other names
Jiuweihuaban Wan
02

Targets

IL-17A (Interleukin-17A)IL22 (Interleukin 22)TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Jiuweihuaban Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiuweihuaban Pill.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call